Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 25%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc is experiencing robust organic growth in the behavioral health sector, aided by an increase in specialty admissions, bed expansions, and new facility developments, positioning the company favorably for future revenue growth. The anticipated rise in net PLGL liability signals positive momentum through enhanced operational efficiencies, while planned reductions in capital expenditures for 2026 are expected to significantly boost cash flow. Furthermore, with strong capitalization and a clearly defined strategy for mergers and acquisitions, Acadia is well-equipped to navigate market challenges and capitalize on growth opportunities within the competitive healthcare landscape.

Bears say

Acadia Healthcare Co. Inc. has faced a series of downward adjustments to its financial guidance, primarily due to underestimated PLGL expenses, which are projected to persist through 2026, impacting the company’s EBITDA significantly. The downward revisions reflect a decline in volume and ongoing rate pressure, leading to a revised adjusted EBITDA estimate of $650-660 million for 2025, which is a reduction of approximately 13.4% from initial guidance. In light of these challenges, analysts anticipate continued softness in volumes and a contraction of the enterprise multiple, ultimately projecting a concerning valuation range for the coming years.

Acadia Healthcare (ACHC) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 25% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 12 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Dec 31, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.